Recommended
Recommended
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

26.43 +0.58 (+2.24%)
Official Closing Price Updated: 7:00 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,360,056
Open 25.82
Bid (Size) 26.37 (900)
Ask (Size) 26.39 (69,500)
Prev. Close 25.85
Today's Range 25.81 - 26.65
52wk Range 20.91 - 27.69
Shares Outstanding 5,606,688,356
Dividend Yield 6.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
These S&P500 stocks are the most active in today's session ↗
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
News headline image
Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst ↗
Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating. 
Via Benzinga
Topics Intellectual Property

Performance

YTD
-0.7%
-0.7%
1 Month
+5.4%
+5.4%
3 Month
+10.3%
+10.3%
6 Month
+8.3%
+8.3%
1 Year
+4.7%
+4.7%

More News

Read More
News headline image
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
From Adaptive Biotechnologies
Via GlobeNewswire
News headline image
Will Dogecoin Reach $1 By the End of the Year? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Forget Teladoc and Buy This Healthcare Stock Instead ↗
Via The Motley Fool
News headline image
Rigani Press Announces Barnes & Noble Book Signing for Dr. S. Yin Ho's Groundbreaking Book
Via PRLog
Topics Artificial Intelligence
News headline image
Pfizer Declares First-Quarter 2026 Dividend
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. ↗
Via The Motley Fool
News headline image
The Best Turnaround Stock to Invest $1,000 in Right Now ↗
Via The Motley Fool
News headline image
The Great Divergence: Investors Retreat from High-Flying Tech as Market Seeks New Equilibrium
Via MarketMinute
Topics Artificial Intelligence Economy Law Enforcement
News headline image
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Value Stocks Stage a Comeback Bid Amidst Persistent Growth Dominance
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Moderna And Super Micro Top S&P 500 Short Interest List — Are They Ripe For A Squeeze? ↗
Via Stocktwits
Topics Artificial Intelligence Stocks
News headline image
Warning: This Skyrocketing Stock Has a Hidden Risk ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer's Tukysa Combo Shows Strong PFS Benefit In Metastatic Breast Cancer ↗
Via Benzinga
News headline image
Markets Brace for Anticipated Fed Rate Cut Amidst Shifting Economic Landscape
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Down 50%, Should You Buy the Dip on Pfizer? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Looking for the most active stocks in the S&P500 index on Tuesday? ↗
Via Chartmill
News headline image
PFE Stock Gains In Premarket – What Is The Deal With Shanghai Fosun Pharma’s Unit About? ↗
Via Stocktwits
News headline image
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
From Pfizer Inc.
Via Business Wire
News headline image
U.S. Households Brace for Financial Headwinds Despite Steady Inflation, New York Fed Reports
Via MarketMinute
Topics Economy
News headline image
Government Relations and Policy Professional Kimberly Pinter Joins Bracewell's Policy Resolution Group in Washington, DC
Via Newsfile
News headline image
How Do Investors Really Feel About Pfizer Inc? ↗
Via Benzinga

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 26.43
When was Pfizer last traded?
The last trade of Pfizer was at 12/15/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 148.18B
How many shares of Pfizer are outstanding?
Pfizer has 148B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.